{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:04:09Z","timestamp":1782965049918,"version":"3.54.5"},"reference-count":56,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T00:00:00Z","timestamp":1449792000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2015,12,11]]},"DOI":"10.3233\/jhd-150171","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T09:26:48Z","timestamp":1451381208000},"page":"287-296","source":"Crossref","is-referenced-by-count":22,"title":["PET Imaging in Huntington\u2019s Disease"],"prefix":"10.1177","volume":"4","author":[{"given":"Andreas-Antonios","family":"Roussakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"3","key":"10.3233\/JHD-150171_ref1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/brain\/118.3.689","article-title":"Striatal D1 and D2 receptor binding in patients withHuntington\u2019s disease and other choreas. A PET study","volume":"118","author":"Turjanski","year":"1995","journal-title":"Brain"},{"issue":"1","key":"10.3233\/JHD-150171_ref2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410400110","article-title":"Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington\u2019s disease","volume":"40","author":"Weeks","year":"1996","journal-title":"Ann Neurol"},{"issue":"6","key":"10.3233\/JHD-150171_ref3","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","article-title":"Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington\u2019s disease","volume":"119","author":"Antonini","year":"1996","journal-title":"Brain"},{"issue":"2","key":"10.3233\/JHD-150171_ref4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.410430216","article-title":"[11C]raclopride-PET studies of the Huntington\u2019s disease rate of progression: Relevance of the trinucleotide repeat length","volume":"43","author":"Antonini","year":"1998","journal-title":"Ann Neurol"},{"issue":"11","key":"10.3233\/JHD-150171_ref5","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awg119","article-title":"Progressive striatal and cortical dopamine receptor dysfunction in Huntington\u2019s disease: A PET study","volume":"126","author":"Pavese","year":"2003","journal-title":"Brain"},{"issue":"5","key":"10.3233\/JHD-150171_ref6","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/brain\/awm217","article-title":"Thalamic metabolism and symptom onset in preclinical Huntington\u2019s disease","volume":"130","author":"Feigin","year":"2007","journal-title":"Brain"},{"issue":"2","key":"10.3233\/JHD-150171_ref7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2008.02390.x","article-title":"Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington\u2019s disease","volume":"16","author":"van Oostrom","year":"2009","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.3233\/JHD-150171_ref8","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1172\/JCI69411","article-title":"Metabolic network as a progression biomarker of premanifest Huntington\u2019s disease","volume":"123","author":"Tang","year":"2013","journal-title":"J Clin Invest"},{"issue":"3","key":"10.3233\/JHD-150171_ref9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington\u2019s disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"issue":"12","key":"10.3233\/JHD-150171_ref10","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington\u2019s disease progression. PET and clinical observations","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"issue":"6","key":"10.3233\/JHD-150171_ref11","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/01.wnl.0000176071.08694.cc","article-title":"Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease","volume":"65","author":"van Oostrom","year":"2005","journal-title":"Neurology"},{"issue":"9","key":"10.3233\/JHD-150171_ref12","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/WNL.54.9.1753","article-title":"Decreased striatal monoaminergic terminals in Huntington disease","volume":"54","author":"Bohnen","year":"2000","journal-title":"Neurology"},{"issue":"12","key":"10.3233\/JHD-150171_ref13","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/brain\/120.12.2207","article-title":"Cognitive deficits in Huntington\u2019s disease are predicted by dopaminergic PET markers and brain volumes","volume":"120","author":"B\u00e4ckman","year":"1997","journal-title":"Brain"},{"issue":"11","key":"10.3233\/JHD-150171_ref14","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/brain\/awn244","article-title":"Hypothalamic involvement in Huntington\u2019s disease: An in vivo PET study","volume":"131","author":"Politis","year":"2008","journal-title":"Brain"},{"issue":"9","key":"10.3233\/JHD-150171_ref15","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/brain\/120.9.1553","article-title":"Central motor processing in Huntington\u2019s disease. A PET study","volume":"120","author":"Bartenstein","year":"1997","journal-title":"Brain"},{"issue":"5","key":"10.3233\/JHD-150171_ref16","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/brain\/113.5.1405","article-title":"Cortical and subcortical glucose consumption measured by PET in patients with Huntington\u2019s disease","volume":"113","author":"Kuwert","year":"1990","journal-title":"Brain"},{"issue":"2","key":"10.3233\/JHD-150171_ref17","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease","volume":"47","author":"Ciarmiello","year":"2006","journal-title":"J Nucl Med"},{"issue":"1","key":"10.3233\/JHD-150171_ref18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3988\/jcn.2013.9.1.21","article-title":"Decreased metabolism in the cerebral cortex in early-stage Huntington\u2019s disease: A possible biomarker of disease progression?","volume":"9","author":"Shin","year":"2013","journal-title":"J Clin Neurol"},{"issue":"1","key":"10.3233\/JHD-150171_ref19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.20684","article-title":"Preclinical Huntington\u2019s disease: Compensatory brain responses during learning","volume":"59","author":"Feigin","year":"2006","journal-title":"Ann Neurol"},{"issue":"9","key":"10.3233\/JHD-150171_ref20","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2967\/jnumed.110.077156","article-title":"Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo","volume":"51","author":"Van Laere","year":"2010","journal-title":"J Nucl Med"},{"issue":"9","key":"10.3233\/JHD-150171_ref21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/00004647-199709000-00003","article-title":"11C-diprenorphine binding in Huntington\u2019s disease: A comparison of region of interest analysis with statistical parametric mapping","volume":"17","author":"Weeks","year":"1997","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"10.3233\/JHD-150171_ref22","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jamaneurol.2014.1954","article-title":"The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease","volume":"71","author":"Russell","year":"2014","journal-title":"JAMA Neurol"},{"issue":"Pt 10","key":"10.3233\/JHD-150171_ref23","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/brain\/awv214","article-title":"Altered PDE10A expression detectable early before symptomatic onset in Huntington\u2019s disease","volume":"138","author":"Niccolini","year":"2015","journal-title":"Brain"},{"issue":"3","key":"10.3233\/JHD-150171_ref24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nn.3318","article-title":"Microglia emerge from erythromyeloid precursors via Pu. 1- and Irf8-dependent pathways","volume":"16","author":"Kierdorf","year":"2013","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.3233\/JHD-150171_ref25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1189\/jlb.0303114","article-title":"Microglia, macrophages, perivascular macrophages, and pericytes: A review of function and identification","volume":"75","author":"Guillemin","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.3233\/JHD-150171_ref26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nn.3668","article-title":"Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage determining factors","volume":"17","author":"Crotti","year":"2014","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.3233\/JHD-150171_ref27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.3233\/JHD-150171_ref28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.02.102","article-title":"DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington\u2019s mice (R6\/2) reveals neuroinflammation and insulin associations","volume":"1088","author":"Crocker","year":"2006","journal-title":"Brain Res"},{"issue":"10","key":"10.3233\/JHD-150171_ref29","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/glia.20526","article-title":"Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington\u2019s disease","volume":"55","author":"Simmons","year":"2007","journal-title":"Glia"},{"issue":"11","key":"10.3233\/JHD-150171_ref30","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: A clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.3233\/JHD-150171_ref31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","article-title":"International Huntington\u2019s Disease Collaborative GrouA new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length","volume":"65","author":"Langbehn","year":"2004","journal-title":"Clin Genet"},{"issue":"7","key":"10.3233\/JHD-150171_ref32","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington\u2019s disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.3233\/JHD-150171_ref33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","article-title":"Increased central microglial activation associated withperipheral cytokine levels in premanifest Huntington\u2019s disease gene carriers","volume":"83","author":"Politis","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.3233\/JHD-150171_ref34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington\u2019s disease: A multimodal imaging study","volume":"32","author":"Politis","year":"2011","journal-title":"Hum Brain Ma"},{"issue":"1","key":"10.3233\/JHD-150171_ref35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroimage.2007.11.011","article-title":"Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation","volume":"40","author":"Fujita","year":"2008","journal-title":"Neuroimage"},{"issue":"3","key":"10.3233\/JHD-150171_ref36","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.neuroimage.2007.09.063","article-title":"Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors","volume":"39","author":"Imaizumi","year":"2008","journal-title":"Neuroimage"},{"issue":"4","key":"10.3233\/JHD-150171_ref37","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.neuroimage.2009.11.056","article-title":"Comparison of [(11)C]-(R)-PK 5 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker","volume":"49","author":"Kreisl","year":"2010","journal-title":"Neuroimage"},{"issue":"7","key":"10.3233\/JHD-150171_ref38","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/brain\/awt145","article-title":"Biomarkers Consortium PET Radioligand Project Team. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer\u2019s disease","volume":"136","author":"Kreisl","year":"2013","journal-title":"Brain"},{"issue":"1","key":"10.3233\/JHD-150171_ref39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2967\/jnumed.110.079459","article-title":"Mixed-affinity binding in humans with 18-kDa translocator protein ligands","volume":"52","author":"Owen","year":"2011","journal-title":"J Nucl Med"},{"issue":"1","key":"10.3233\/JHD-150171_ref40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","article-title":"An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28","volume":"32","author":"Owen","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9246","key":"10.3233\/JHD-150171_ref41","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(00)03310-9","article-title":"Motor and cognitive improvements in patients with Huntington\u2019s disease after neural transplantation","volume":"356","author":"Bachoud\u2013 L\u00e9vi","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.3233\/JHD-150171_ref42","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.58.5.687","article-title":"Bilateral human fetal striatal transplantation in Huntington\u2019s disease","volume":"58","author":"Hauser","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.3233\/JHD-150171_ref43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/brain\/awh003","article-title":"Striatal neural grafting improves cortical metabolism in Huntington\u2019s disease patients","volume":"127","author":"Gaura","year":"2004","journal-title":"Brain"},{"issue":"2","key":"10.3233\/JHD-150171_ref44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.20564","article-title":"Positron emission tomography after fetal transplantation in Huntington\u2019s disease","volume":"58","author":"Furtado","year":"2005","journal-title":"Ann Neurol"},{"issue":"6","key":"10.3233\/JHD-150171_ref45","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jnnp-2012-302441","article-title":"The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington\u2019s disease","volume":"84","author":"Barker","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.3233\/JHD-150171_ref46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000360583","article-title":"Human striatum remodelling after neurotransplantation in Huntington\u2019s disease","volume":"92","author":"Gallina","year":"2014","journal-title":"Stereotact Funct Neurosurg"},{"issue":"11","key":"10.3233\/JHD-150171_ref47","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.3233\/JHD-150171_ref48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/2191-219X-3-47","article-title":"11C-LY703, a positron emission tomographic radioligand for the metabotropic glutamate receptor 1, is unsuitable for imaging in monkey and human brains","volume":"3","author":"Zanotti-Fregonara","year":"2013","journal-title":"EJNMMI Res"},{"issue":"8","key":"10.3233\/JHD-150171_ref49","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2967\/jnumed.113.119891","article-title":"Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMM","volume":"54","author":"Toyohara","year":"2013","journal-title":"J Nucl Med"},{"issue":"4","key":"10.3233\/JHD-150171_ref50","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/jcbfm.2013.243","article-title":"Noninvasive quantification of metabotropic glutamate receptor type 1 with [11C]ITDM: A small-animal PET study","volume":"34","author":"Yamasaki","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JHD-150171_ref51","doi-asserted-by":"crossref","unstructured":"Zanotti-Fregonara P , Xu R , Zoghbi SS , Liow JS , Fujita M , Veronese M , et al. The positron emission tomographic radioligand 18F-FIMX images and quantifies metabotropic glutamate receptor 1 in proportion to the regional density of its gene transcript in human brain. J Nucl Med. 2015. doi:10.2967\/jnumed.115.162461.","DOI":"10.2967\/jnumed.115.162461"},{"issue":"4868","key":"10.3233\/JHD-150171_ref52","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.2841762","article-title":"NMDA receptor losses in putamen from patients with Huntington\u2019s disease","volume":"241","author":"Young","year":"1988","journal-title":"Science"},{"issue":"2","key":"10.3233\/JHD-150171_ref53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.nucmedbio.2014.09.006","article-title":"Preclinical evaluation of [(18)F]PK-209, a new PET ligand for imaging the ion-channel site of NMDA receptors","volume":"42","author":"Golla","year":"2015","journal-title":"Nucl Med Biol"},{"issue":"Pt 4","key":"10.3233\/JHD-150171_ref54","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/awr028","article-title":"Glutamate NMDA receptor dysregulation in Parkinson\u2019s disease with dyskinesias","volume":"134","author":"Ahmed","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JHD-150171_ref55","doi-asserted-by":"crossref","unstructured":"Dhawan V , Robeson W , Bjelke D , Chaly T , Graf K , Hellman M , et al. Human radiation dosimetry for the N-Methyl-D-Aspartate receptor radioligand 11C-CNSJ Nucl Med 2015;56(6):869\u201372.","DOI":"10.2967\/jnumed.114.152447"},{"issue":"3","key":"10.3233\/JHD-150171_ref56","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2967\/jnumed.113.130641","article-title":"Initial evaluation of 18F-GE-179, a putative PET Tracer for activated N-methyl D-aspartate receptors","volume":"55","author":"McGinnity","year":"2014","journal-title":"J Nucl Med"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-150171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:57:06Z","timestamp":1777453026000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-150171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,11]]},"references-count":56,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jhd-150171","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,11]]}}}